Matthew J. Akiyama, M.D.

Medicine

Phone718-405-8040
Emailmakiyama@montefiore.org
Websitehttp://www.einstein.yu.edu/faculty/14789/matthew-akiyama/

Source: Scopus
Calculated based on no. of publications stored in Pure and citations from Scopus

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint

Dive into the research topics where Matthew J. Akiyama is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

11 Similar Profiles

Network

Recent external collaboration on country level. Dive into details by clicking on the dots.

1 Active

Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial
Akiyama, M. J.
NATIONAL INSTITUTE ON DRUG ABUSE
8/15/17 → 3/31/21
Project: Research project

211 Citations
9 h-Index
22 Article
5 Review article
2 Comment/debate
1 Letter

A phylogenetic analysis of hepatitis C virus transmission, relapse, and reinfection among people who inject drugs receiving opioid agonist therapy
Akiyama, M. J., Lipsey, D., Ganova-Raeva, L., Punkova, L. T., Agyemang, L., Sue, A., Ramachandran, S., Khudyakov, Y. & Litwin, A. H., Aug 1 2020, In : Journal of Infectious Diseases. 222, 3, p. 488-498 11 p.
Research output: Contribution to journal › Article › peer-review
Artificial intelligence platform demonstrates high adherence in patients receiving fixed-dose ledipasvir and sofosbuvir: A pilot study
Litwin, A. H., Shafner, L., Norton, B., Akiyama, M. J., Agyemang, L., Guzman, M., Vera, T. & Heo, M., Aug 1 2020, In : Open Forum Infectious Diseases. 7, 8, ofaa290.
Research output: Contribution to journal › Article › peer-review

Open Access
Cost-effectiveness of hepatitis C virus treatment models for people who inject drugs in opioid agonist treatment programs
Gutkind, S., Schackman, B. R., Morgan, J. R., Leff, J. A., Agyemang, L., Murphy, S. M., Akiyama, M. J., Norton, B. L., Litwin, A. H. & Linas, B. P., Mar 17 2020, In : Clinical Infectious Diseases. 70, 7, p. 1397-1405 9 p.
Research output: Contribution to journal › Article › peer-review
3 Scopus citations
Flattening the curve for incarcerated populations - Covid-19 in jails and prisons
Akiyama, M. J., Spaulding, A. C. & Rich, J. D., May 28 2020, In : New England Journal of Medicine. 382, 22, p. 2075-2077 3 p.
Research output: Contribution to journal › Review article › peer-review

Open Access

50 Scopus citations
Hepatitis C in the criminal justice system: Opportunities for global action in the era of viral hepatitis elimination
Akiyama, M. J., Aug 14 2020, In : BMC Medicine. 18, 1, 208.
Research output: Contribution to journal › Comment/debate › peer-review

Open Access

Advance Care Coordination and Enhanced Linkage and Retention Among Transitional Re-Entrants Living with Hepatitis C-The HCV-ACCELERATE Trial

A phylogenetic analysis of hepatitis C virus transmission, relapse, and reinfection among people who inject drugs receiving opioid agonist therapy

Artificial intelligence platform demonstrates high adherence in patients receiving fixed-dose ledipasvir and sofosbuvir: A pilot study

Cost-effectiveness of hepatitis C virus treatment models for people who inject drugs in opioid agonist treatment programs

Flattening the curve for incarcerated populations - Covid-19 in jails and prisons

Hepatitis C in the criminal justice system: Opportunities for global action in the era of viral hepatitis elimination